Inventor · disambiguated record
James R. Corte
Also filed as: CORTE JAMES R
65 granted patents·13 pending applications·345 citations·filing 2002–2024
98Inventor score
Top patents by PatentIndex Score
78 records- 0198US10662172B2Triazole N-linked carbamoyl cyclohexyl acids as LPA antagonistsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted May 26, 2020·30 cites·121 claims
- 0297US10576062B2Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonistsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Mar 3, 2020·18 cites·18 claims
- 0397US7459564B2Substituted biaryl compounds as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Dec 2, 2008·26 cites·14 claims
- 0496US10071078B2Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonistsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Sep 11, 2018·21 cites·16 claims
- 0596US9453018B2Pyrimidinones as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Sep 27, 2016·13 cites·17 claims
- 0694US11007180B2Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonistsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted May 18, 2021·3 cites·1 claims
- 0794US7453002B2Five-membered heterocycles useful as serine protease inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Nov 18, 2008·24 cites·17 claims
- 0893US10208068B2Macrocycles as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Feb 19, 2019·5 cites·3 claims
- 0993US7417063B2Bicyclic heterocycles useful as serine protease inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Aug 26, 2008·27 cites·14 claims
- 1092US9902742B2Macrocycles as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Feb 27, 2018·5 cites·13 claims
- 1192US9611274B2Macrocycles as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Apr 4, 2017·5 cites·14 claims
- 1292US8828983B2Macrocycles as factor XIa inhibitorsQUAN MIMI L·Filed 2011·Granted Sep 9, 2014·13 cites·14 claims
- 1391US10487086B2Macrocycles as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Nov 26, 2019·3 cites·9 claims
- 1491US9221818B2Macrocycles as factor XIa inhibitorsPINTO DONALD J P·Filed 2012·Granted Dec 29, 2015·13 cites·11 claims
- 1591US8940720B2Macrocycles as factor XIa inhibitorsCORTE JAMES R·Filed 2011·Granted Jan 27, 2015·6 cites·4 claims
- 1691US7626039B2Arylpropionamide, arylacrylamide, ayrlpropynamide, or arylmethylurea analogs as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Dec 1, 2009·14 cites·14 claims
- 1791US7429604B2Six-membered heterocycles useful as serine protease inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Sep 30, 2008·35 cites·20 claims
- 1890US7645799B2Substituted biaryl compounds as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jan 12, 2010·7 cites·16 claims
- 1990US7141578B2Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor functionBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Nov 28, 2006·17 cites·14 claims
- 2089US9802939B2Macrocycles as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Oct 31, 2017·3 cites·9 claims
- 2188US2025057815A1Carbamoyloxymethyl triazole cyclohexyl acids as lpa antagonistsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 2287US11053247B2Pyrimidinones as factor XIA inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jul 6, 2021·2 cites·9 claims
- 2386US12195444B2Triazole n-linked carbamoyl cyclohexyl acids as LPA antagonistsBRISTOL MYERS SQUIBB CO·Filed 2023·Granted Jan 14, 2025·0 cites·20 claims
- 2486US11136327B2Macrocycles as factor XIA inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Oct 5, 2021·1 cites·11 claims
- 2586US10336754B2Pyrimidinones as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jul 2, 2019·2 cites·17 claims
- 2686US9453029B2Macrocycles as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Sep 27, 2016·2 cites·13 claims
- 2786US2023390249A1Carbamoyloxymethyl triazole cyclohexyl acids as lpa antagonistsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 2885US9079918B2Macrocycles as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jul 14, 2015·2 cites·12 claims
- 2984US9108951B2Substituted 5,6,7,8-tetrahydro-1,6-naphthyridines as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2012·Granted Aug 18, 2015·5 cites·6 claims
- 3084US8163749B2Six-membered heterocycles useful as serine protease inhibitorsCORTE JAMES R·Filed 2006·Granted Apr 24, 2012·8 cites·10 claims
- 3183US7842708B2Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Nov 30, 2010·4 cites·16 claims
- 3282US8101778B2Five-membered heterocycles useful as serine protease inhibitorsHANGELAND JON J·Filed 2008·Granted Jan 24, 2012·5 cites·2 claims
- 3382US7517904B2Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor functionBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Apr 14, 2009·1 cites·3 claims
- 3481US11352345B2Cyclohexyl acid pyrazole azoles as LPA antagonistsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jun 7, 2022·1 cites·3 claims
- 3581US11267800B2Cyclohexyl acid triazole azines as LPA antagonistsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Mar 8, 2022·2 cites·31 claims
- 3680US12404274B2Macrocycles as factor xia inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Sep 2, 2025·0 cites·8 claims
- 3779US8324199B2Pyridazine derivatives as factor xia inhibitorsCORTE JAMES R·Filed 2009·Granted Dec 4, 2012·4 cites·9 claims
- 3879US2022249443A1Carbamoyloxymethyl triazole cyclohexyl acids as lpa antagonistsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 3978US9777001B2Macrocycles with aromatic P2′ groups as factor xia inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Oct 3, 2017·3 cites·11 claims
- 4078US2025057995A1Radioligands for imaging the lpa1 receptorBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 4177US12428421B2Pyrimidinones as factor XIA inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Sep 30, 2025·0 cites·31 claims
- 4277US10000466B2Substituted 4,5,6,7-tetrahydropyrazolo[3,4-c]pyridines as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jun 19, 2018·1 cites·5 claims
- 4375US8716492B2Five-membered heterocycles useful as serine protease inhibitorsHANGELAND JON J·Filed 2011·Granted May 6, 2014·2 cites·10 claims
- 4475US2021244711A1Carbamoyloxymethyl triazole cyclohexyl acids as lpa antagonistsBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 4574US10336730B2Substituted glycine derived FXIA inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jul 2, 2019·1 cites·10 claims
- 4674US9409908B2Dihydropyridone p1 as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Aug 9, 2016·1 cites·14 claims
- 4774US7655689B2Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor functionBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Feb 2, 2010·1 cites·13 claims
- 4873USRE49352ECarbamoyloxymethyl triazole cyclohexyl acids as LPA antagonistsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Jan 3, 2023·0 cites·25 claims
- 4972US11697646B2Triazole N-linked carbamoyl cyclohexyl acids as LPA antagonistsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Jul 11, 2023·0 cites·20 claims
- 5072US11319315B2Cyclohexyl acid triazole azoles as LPA antagonistsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted May 3, 2022·1 cites·30 claims
Showing the top 50 of 78 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when James R. Corte files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →